| 2024 |
ArriVent BioPharma Inc.
|
Chief Financial Officer, Principal Accounting Officer and Treasurer |
1.8 M |
- |
| 2024 |
PMV Pharmaceuticals Inc
|
Chief Operating Officer, Principal Accounting Officer and Chief Financial Officer |
- |
- |
| 2023 |
PMV Pharmaceuticals Inc
|
Chief Operating Officer, Principal Accounting Officer and Chief Financial Officer |
1.3 M |
-28.7 % |
| 2023 |
ArriVent BioPharma Inc.
|
Chief Financial Officer, Principal Accounting Officer and Treasurer |
- |
- |
| 2022 |
PMV Pharmaceuticals Inc
|
Chief Operating Officer, Principal Accounting Officer and Chief Financial Officer |
1.8 M |
6.2 % |
| 2022 |
ArriVent BioPharma Inc.
|
Chief Financial Officer and Treasurer |
- |
- |
| 2021 |
PMV Pharmaceuticals Inc
|
- |
1.7 M |
101.8 % |
| 2021 |
PMV Pharmaceuticals Inc
|
Chief Operating Officer, Principal Accounting Officer and Chief Financial Officer |
1.7 M |
101.8 % |
| 2020 |
PMV Pharmaceuticals Inc
|
Chief Operating Officer, Principal Accounting Officer and Chief Financial Officer |
825.4 K |
46.7 % |
| 2020 |
PMV Pharmaceuticals Inc
|
- |
825.1 K |
46.7 % |
| 2020 |
PMV Pharmaceuticals Inc
|
- |
825.1 K |
46.7 % |
| 2019 |
PMV Pharmaceuticals Inc
|
- |
562.4 K |
- |
| 2019 |
PMV Pharmaceuticals Inc
|
- |
562.4 K |
- |
| 2019 |
PMV Pharmaceuticals Inc
|
Chief Operating Officer and Chief Financial Officer |
562.4 K |
- |